Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Journal . 2026
License: CC BY NC ND
Data sources: ZENODO
ZENODO
Journal . 2026
License: CC BY NC ND
Data sources: Datacite
ZENODO
Journal . 2026
License: CC BY NC ND
Data sources: Datacite
versions View all 2 versions
addClaim

Boletín Fármacos: Farmacovigilancia 2026; 29(2)

Authors: Castrillon Valencia, Natalia Katerine; Homedes, Nuria; Ugalde, Antonio;

Boletín Fármacos: Farmacovigilancia 2026; 29(2)

Abstract

Boletín Fármacos es un boletín electrónico de la organización Salud y Fármacos [https://www.saludyfarmacos.org/] que se publica cuatro veces al año en febrero, mayo, agosto y noviembre. El Boletín Fármacos: Farmacovigilancia incluye artículos y notas informativas sobre la seguridad de los medicamentos. Abarca temas de investigación; alertas por la solicitud y/o retirada del mercado de medicamentos; los cambios a las etiquetas fichas técnicas de los medicamentos; información sobre posibles interacciones fármaco-fármaco, reacciones adversas; y algunos otros informes de farmacovigilancia. Está sección suele incluir traducciones de los reconocidos boletines: Worst Pills, Best Pills (Public Citizen) y Prescrire International. Este documento corresponde al 2026, Vol. 29, N°2.

Keywords

interacciones medicamentosas, farmacovigilancia, reacciones adversas, retiros del mercado, precauciones

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average